Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure
NCT: NCT06418932 · COMPLETED
Brief Summary
Randomized 1:1 multicenter double-blind clinical investigation evaluating the efficacy and safety of compression therapy of the lower limbs plus parenteral administration of diuretics vs. administration of parenteral diuretics alone (standard treatment) in patients with decompensated HF and predominantly systemic tissue congestion and absence of intravascular systemic congestion. Patients will be assigned to standard treatment (parenteral administration of furosemide) versus parenteral administration of furosemide plus lower limb compression therapy for up to 72 hours. The dose of furosemide in all participants will be based on the clinical judgment of the responsible healthcare professional.
Frequently Asked Questions
What is Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure?
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure is a clinical trial registered under NCT06418932. Current status: COMPLETED.
What is the status of NCT06418932?
The current status of NCT06418932 (Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure) is: COMPLETED.
When did Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure start?
Compression Therapy of the Lower Limbs in Patients With Decompensated Heart Failure started on 2024-05-27.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.